Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,940
Closed -$4.58M 150
2023
Q1
$4.58M Buy
18,940
+2,258
+14% +$554K 0.42% 51
2022
Q4
$4.38M Buy
+16,682
New +$4.47M 0.43% 52
2021
Q3
Sell
-829
Closed -$202K 119
2021
Q2
$202K Sell
829
-273
-25% -$67.2K 0.02% 114
2021
Q1
$274K Sell
1,102
-161
-13% -$38.4K 0.04% 89
2020
Q4
$290K Buy
+1,263
New +$291K 0.04% 86

Other funds holding AMGN

TruWealth Advisors's AMGN Position: Q2 2023 in Review

TruWealth Advisors sold out of Amgen (AMGN) in Q2 2023, closing a stake of 18,940 shares — an estimated $4.58M sold.

TruWealth Advisors first reported a position in AMGN in Q4 2020 and held it in 5 quarters. The position peaked at $4.58M in Q1 2023. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • TruWealth Advisors reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • TruWealth Advisors sold 18,940 Amgen shares in Q2 2023, an estimated $4.58M.
  • TruWealth Advisors first reported a position in Amgen in Q4 2020 and held it in 5 quarters.
  • TruWealth Advisors's Amgen position peaked at $4.58M in Q1 2023.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on TruWealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.